Skip to main content

Table 1 Baseline characteristics of the patients

From: Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure

  NA group (mean ± SD) Non-NA group (mean ± SD) t or χ 2 value P value
Male (%) 52 (85.25) 59 (84.29) 0.02 0.88
HBeAg positive (%) 19 (31.15) 18 (25.71) 0.48 0.49
Age (yr) 40.31 ± 10.75 43.14 ± 10.37 -1.53 0.13
HBV DNA log10 (copies/ml) 5.72 ± 1.38 5.31 ± 1.56 1.53 0.13
TBIL (μmol/L) 278.56 ± 116.09 260.24 ± 115.50 0.90 0.37
Albumin (g/L) 34.73 ± 5.85 34.35 ± 4.49 0.42 0.67
ALT (U/L) 1037.44 ± 823.50 833.93 ± 794.70 1.44 0.15
PTA (%) 31.15 ± 9.71 33.34 ± 10.20 -1.25 0.21
Creatinine (μmol/L) 66.01 ± 12.46 76.94 ± 52.23 -1.70 0.09
MELD Score 22.82 ± 2.99 23.95 ± 5.91 -1.40 0.17